|
GNG12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.448930E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.24030000000642E-05 |
| Normal-vs-Stage2 |
1.324340E-02 |
| Normal-vs-Stage3 |
2.095000E-01 |
| Normal-vs-Stage4 |
9.894200E-02 |
| Stage1-vs-Stage2 |
8.721600E-01 |
| Stage1-vs-Stage3 |
1.677980E-01 |
| Stage1-vs-Stage4 |
5.900800E-01 |
| Stage2-vs-Stage3 |
4.218600E-01 |
| Stage2-vs-Stage4 |
7.151800E-01 |
| Stage3-vs-Stage4 |
7.598000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.550100E-04 |
| Normal-vs-AfricanAmerican |
1.573090E-04 |
| Normal-vs-Asian |
1.396430E-02 |
| Caucasian-vs-AfricanAmerican |
3.754600E-01 |
| Caucasian-vs-Asian |
5.629800E-01 |
| AfricanAmerican-vs-Asian |
6.648200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.93680000000796E-05 |
| Normal-vs-Female |
1.101720E-02 |
| Male-vs-Female |
2.861400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.955470E-04 |
| Normal-vs-Extreme_Weight |
4.18250000000508E-05 |
| Normal-vs-Obese |
3.302200E-02 |
| Normal-vs-Extreme_Obese |
7.984800E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.391200E-01 |
| Normal_Weight-vs-Obese |
1.142970E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.693000E-01 |
| Extreme_Weight-vs-Obese |
1.151810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.393200E-01 |
| Obese-vs-Extreme_Obese |
4.280800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.183400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.136600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.6046999999908E-05 |
| Normal-vs-Age(81-100Yrs) |
1.142090E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.563600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.925900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.466360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.235800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.788830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.592000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.787900E-04 |
| Normal-VS-Type2 PRCC |
1.617920E-03 |
| Normal-VS-KIRP CIMP |
7.843800E-01 |
| Normal-VS-Unclassified PRCC |
4.846800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.687800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.374420E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.672200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.059900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.500000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.047000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.354500E-04 |
| Normal-vs-N1 |
4.529600E-01 |
| Normal-vs-N2 |
1.298820E-01 |
| N0-vs-N1 |
4.894000E-02 |
| N0-vs-N2 |
7.840200E-01 |
| N1-vs-N2 |
5.658800E-01 |
|
|
